{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:52:21Z","timestamp":1792842741368,"version":"4.5.0"},"reference-count":150,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T00:00:00Z","timestamp":1570233600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nefrolog\u00eda"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.nefro.2019.06.009","type":"journal-article","created":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T01:27:58Z","timestamp":1573781278000},"page":"12-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Melatonin ameliorates the drug induced nephrotoxicity: Molecular insights"],"prefix":"10.1016","volume":"40","author":[{"given":"Zohaib","family":"Raza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab","family":"Naureen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefro.2019.06.009_bib0755","first-page":"57","article-title":"Drug-induced renal disorders","volume":"4","author":"Ghane Shahrbaf","year":"2015","journal-title":"J Renal Injury Prev"},{"key":"10.1016\/j.nefro.2019.06.009_bib0760","first-page":"555","article-title":"Drug-induced acute kidney injury","volume":"11","author":"Schetz","year":"2005","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.nefro.2019.06.009_bib0765","first-page":"743","article-title":"Drug-induced nephrotoxicity","volume":"78","author":"Naughton","year":"2008","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.nefro.2019.06.009_bib0770","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/ndt\/15.2.212","article-title":"Treatment-related acute renal failure in the elderly: a hospital-based prospective study","volume":"15","author":"Kohli","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefro.2019.06.009_bib0775","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1021\/mp400720w","article-title":"Drug-induced nephrotoxicity: clinical impact and preclinical in vitro models","volume":"11","author":"Tiong","year":"2014","journal-title":"Mol Pharm"},{"key":"10.1016\/j.nefro.2019.06.009_bib0780","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0272-6386(00)70348-9","article-title":"Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future","volume":"35","author":"de Mattos","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nefro.2019.06.009_bib0785","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2165\/00002018-200124010-00003","article-title":"Anticancer drug-induced kidney disorders","volume":"24","author":"Kintzel","year":"2001","journal-title":"Drug Saf"},{"key":"10.1016\/j.nefro.2019.06.009_bib0790","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1097\/00007890-200203270-00035","article-title":"Tacrolimus-induced nephrotoxicity unmasked by induction of the CYP3A4 system with St John's wort","volume":"73","author":"Bolley","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.nefro.2019.06.009_bib0795","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1053\/ajkd.2003.50037","article-title":"Drug-induced Fanconi's syndrome","volume":"41","author":"Izzedine","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nefro.2019.06.009_bib0800","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1053\/ajkd.2002.36924","article-title":"Fanconi syndrome and renal failure induced by tenofovir: a first case report","volume":"40","author":"Verhelst","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nefro.2019.06.009_bib0805","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1021\/ja01543a060","article-title":"Isolation of melatonin, the pineal gland factor that lightens melanocytes 1","volume":"80","author":"Lerner","year":"1958","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.nefro.2019.06.009_bib0810","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1210\/edrv-12-2-151","article-title":"Pineal melatonin: cell biology of its synthesis and of its physiological interactions","volume":"12","author":"Reiter","year":"1991","journal-title":"Endocr Rev"},{"key":"10.1016\/j.nefro.2019.06.009_bib0815","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.pneurobio.2008.04.001","article-title":"Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways","volume":"85","author":"Pandi-Perumal","year":"2008","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.nefro.2019.06.009_bib0820","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.smrv.2004.08.001","article-title":"The basic physiology and pathophysiology of melatonin","volume":"9","author":"Claustrat","year":"2005","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.nefro.2019.06.009_bib0825","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.18388\/abp.2003_3637","article-title":"Melatonin as an antioxidant: biochemical mechanisms and pathophysiological implications in humans","volume":"50","author":"Reiter","year":"2003","journal-title":"Acta Biochim Pol"},{"key":"10.1016\/j.nefro.2019.06.009_bib0830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2014.04.031","article-title":"Melatonin stimulates antioxidant enzymes and reduces oxidative stress in experimental traumatic brain injury: the Nrf2-ARE signaling pathway as a potential mechanism","volume":"73","author":"Ding","year":"2014","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.nefro.2019.06.009_bib0835","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1600-079X.2011.00960.x","article-title":"Melatonin enhances endogenous heme oxygenase-1 and represses immune responses to ameliorate experimental murine membranous nephropathy","volume":"52","author":"Wu","year":"2012","journal-title":"J Pineal Res"},{"key":"10.1016\/j.nefro.2019.06.009_bib0840","doi-asserted-by":"crossref","first-page":"F910","DOI":"10.1152\/ajprenal.2000.279.5.F910","article-title":"Melatonin attenuates acute renal failure and oxidative stress induced by mercuric chloride in rats","volume":"279","author":"Nava","year":"2000","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.nefro.2019.06.009_bib0845","first-page":"153","article-title":"Effect of melatonin on carbon tetrachloride-induced kidney injury in wistar rats","volume":"10","author":"Adewole","year":"2007","journal-title":"Afr J Biomed Res"},{"key":"10.1016\/j.nefro.2019.06.009_bib0850","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-079X.2007.00447.x","article-title":"Melatonin reduces uranium-induced nephrotoxicity in rats","volume":"43","author":"Belles","year":"2007","journal-title":"J Pineal Res"},{"key":"10.1016\/j.nefro.2019.06.009_bib0855","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1876528900902010001","article-title":"Melatonin ameliorates cadmium-induced oxidative damage and morphological changes in the kidney of rat","volume":"2","author":"El-Sokkary","year":"2009","journal-title":"Open Neuroendocrinol J"},{"key":"10.1016\/j.nefro.2019.06.009_bib0860","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1191\/0960327102ht225oa","article-title":"Nephrotoxicity in rats induced by chlorpryfos-ethyl and ameliorating effects of antioxidants","volume":"21","author":"Oncu","year":"2002","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.nefro.2019.06.009_bib0865","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3181\/0802-RM-65","article-title":"Establishing the use of melatonin as an adjuvant therapeutic against paraquat-induced lung toxicity in rats","volume":"233","author":"Gocgeldi","year":"2008","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.nefro.2019.06.009_bib0870","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1600-079X.2010.00805.x","article-title":"The mechanism for the neuroprotective effect of melatonin against methamphetamine-induced autophagy","volume":"49","author":"Nopparat","year":"2010","journal-title":"J Pineal Res"},{"key":"10.1016\/j.nefro.2019.06.009_bib0875","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1742-1241.2006.01191.x","article-title":"Melatonin: therapeutic and clinical utilization","volume":"61","author":"Altun","year":"2007","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.nefro.2019.06.009_bib0880","doi-asserted-by":"crossref","first-page":"268","DOI":"10.4062\/biomolther.2012.20.3.268","article-title":"Drug-induced nephrotoxicity and its biomarkers","volume":"20","author":"Kim","year":"2012","journal-title":"Biomol Ther"},{"key":"10.1016\/j.nefro.2019.06.009_bib0885","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1172\/JCI116737","volume":"92","author":"Satriano","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nefro.2019.06.009_bib0890","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0962-8924(91)90072-H","article-title":"A role for oxygen radicals as second messengers","volume":"1","author":"Schreck","year":"1991","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.nefro.2019.06.009_bib0895","doi-asserted-by":"crossref","first-page":"a001651","DOI":"10.1101\/cshperspect.a001651","article-title":"The nuclear factor NF-kappaB pathway in inflammation","volume":"1","author":"Lawrence","year":"2009","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.nefro.2019.06.009_bib0900","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1749-6632.2000.tb05402.x","article-title":"Melatonin and its relation to the immune system and inflammation","volume":"917","author":"Reiter","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.nefro.2019.06.009_bib0905","doi-asserted-by":"crossref","first-page":"F336","DOI":"10.1152\/ajprenal.00500.2007","article-title":"Melatonin ameliorates oxidative stress, inflammation, proteinuria, and progression of renal damage in rats with renal mass reduction","volume":"294","author":"Quiroz","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.nefro.2019.06.009_bib0910","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0168-8278(03)00504-X","article-title":"Melatonin inhibits nuclear factor kappa B activation and oxidative stress and protects against thioacetamide induced liver damage in rats","volume":"40","author":"Bruck","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.nefro.2019.06.009_bib0915","first-page":"49","article-title":"Both melatonin and a putative nuclear melatonin receptor agonist CGP 52608 stimulate glutathione peroxidase and glutathione reductase activities in mouse brain in vivo","volume":"18","author":"Pablos","year":"1998","journal-title":"Neuroendocrinol Lett"},{"key":"10.1016\/j.nefro.2019.06.009_bib0920","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1749-6632.1994.tb21831.x","article-title":"Melatonin \u2013 a highly potent endogenous radical scavenger and electron donor: new aspects of the oxidation chemistry of this indole accessed in vitro","volume":"738","author":"Poeggeler","year":"1994","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.nefro.2019.06.009_bib0925","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0197-0186(94)00154-M","article-title":"Melatonin stimulates brain glutathione peroxidase activity","volume":"26","author":"Barlow-Walden","year":"1995","journal-title":"Neurochem Int"},{"key":"10.1016\/j.nefro.2019.06.009_bib0930","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1600-079X.1995.tb00178.x","article-title":"Melatonin stimulates the activity of the detoxifying enzyme glutathione peroxidase in several tissues of chicks","volume":"19","author":"Pablos","year":"1995","journal-title":"J Pineal Res"},{"key":"10.1016\/j.nefro.2019.06.009_bib0935","first-page":"365","article-title":"The effect of melatonin on glutathione and glutathione transferase and glutathione peroxidase activities in the mouse liver and kidney in vivo","volume":"27","author":"Swiderska-Kolacz","year":"2006","journal-title":"Neuroendocrinol Lett"},{"key":"10.1016\/j.nefro.2019.06.009_bib0940","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4077\/CJP.2017.BAF435","article-title":"Protective effects of melatonin on the activity of SOD, CAT GSH-Px and GSH content in organs of mice after administration of SNP","volume":"60","author":"Goc","year":"2017","journal-title":"Chin J Physiol"},{"key":"10.1016\/j.nefro.2019.06.009_bib0945","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0197-0186(97)00043-0","article-title":"Rhythms of glutathione peroxidase and glutathione reductase in brain of chick and their inhibition by light","volume":"32","author":"Pablos","year":"1998","journal-title":"Neurochem Int"},{"key":"10.1016\/j.nefro.2019.06.009_bib0950","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/cbf.994","article-title":"Melatonin effect on renal oxidative stress under constant light exposure","volume":"21","author":"Tunez","year":"2003","journal-title":"Cell Biochem Funct"},{"key":"10.1016\/j.nefro.2019.06.009_bib0955","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1006\/phrs.2001.0837","article-title":"Effects of melatonin on enzyme activities of glucose-6-phosphate dehydrogenase from human erythrocytes in vitro and from rat erythrocytes in vivo","volume":"44","author":"Ciftci","year":"2001","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.nefro.2019.06.009_bib0960","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0531-5565(94)00036-3","article-title":"Oxygen free radicals, melatonin, and aging","volume":"30","author":"Pierrefiche","year":"1995","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.nefro.2019.06.009_bib0965","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1600-079X.1998.tb00383.x","article-title":"Physiological concentrations of melatonin inhibit the norepinephrine-induced activation of prostaglandin E2 and cyclic AMP production in rat hypothalamus: a mechanism involving inhibiton of nitric oxide synthase","volume":"25","author":"Bettahi","year":"1998","journal-title":"J Pineal Res"},{"key":"10.1016\/j.nefro.2019.06.009_bib0970","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0149-7634(05)80016-8","article-title":"The significance of the metabolism of the neurohormone melatonin: antioxidative protection and formation of bioactive substances","volume":"17","author":"Hardeland","year":"1993","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.nefro.2019.06.009_bib0975","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1021\/jm980117m","article-title":"Reactions of melatonin and related indoles with free radicals: a computational study","volume":"41","author":"Turjanski","year":"1998","journal-title":"J Med Chem"},{"key":"10.1016\/j.nefro.2019.06.009_bib0980","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1385\/CBB:34:2:237","article-title":"Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence","volume":"34","author":"Reiter","year":"2001","journal-title":"Cell Biochem Biophys"},{"key":"10.1016\/j.nefro.2019.06.009_bib0985","first-page":"305","article-title":"Melatonin reduces oxidative stress induced by ochratoxin A in rat liver and kidney","volume":"130","author":"Meki","year":"2001","journal-title":"Comp Biochem Physiol C: Toxicol Pharmacol"},{"key":"10.1016\/j.nefro.2019.06.009_bib0990","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1442-2042.2007.01806.x","article-title":"Protective effects of melatonin on renal failure in pinealectomized rats","volume":"14","author":"Parlakpinar","year":"2007","journal-title":"Int J Urol"},{"key":"10.1016\/j.nefro.2019.06.009_bib0995","series-title":"Oxygen free radicals in tissue damage","first-page":"12","article-title":"Oxygen free radicals and tissue injury","author":"Borg","year":"1993"},{"key":"10.1016\/j.nefro.2019.06.009_bib1000","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1006\/bbrc.1998.9826","article-title":"A novel melatonin metabolite, cyclic 3-hydroxymelatonin: a biomarker of in vivo hydroxyl radical generation","volume":"253","author":"Tan","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.nefro.2019.06.009_bib1005","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0891-5849(00)00435-4","article-title":"Melatonin directly scavenges hydrogen peroxide: a potentially new metabolic pathway of melatonin biotransformation","volume":"29","author":"Tan","year":"2000","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.nefro.2019.06.009_bib1010","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1179\/135100003225002709","article-title":"Antioxidant properties of the melatonin metabolite N1-acetyl-5-methoxykynuramine (AMK): scavenging of free radicals and prevention of protein destruction","volume":"8","author":"Ressmeyer","year":"2003","journal-title":"Redox Rep"},{"key":"10.1016\/j.nefro.2019.06.009_bib1015","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1743-7075-2-22","article-title":"Melatonin, a potent agent in antioxidative defense: actions as a natural food constituent, gastrointestinal factor, drug and prodrug","volume":"2","author":"Hardeland","year":"2005","journal-title":"Nutr Metab"},{"key":"10.1016\/j.nefro.2019.06.009_bib1020","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/164_2016_6","article-title":"The emerging role of mitochondrial targeting in kidney disease","volume":"240","author":"Eirin","year":"2017","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.nefro.2019.06.009_bib1025","first-page":"246","article-title":"Melatonin: lowering the high price of free radicals","volume":"15","author":"Reiter","year":"2000","journal-title":"News Physiol Sci"},{"key":"10.1016\/j.nefro.2019.06.009_bib1030","first-page":"373","article-title":"The universal nature unequal distribution and antioxidant functions of melatonin and its derivatives","volume":"13","author":"Reiter","year":"2013","journal-title":"Mini-Rev Med Chem"},{"key":"10.1016\/j.nefro.2019.06.009_bib1035","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1600-079X.1993.tb00511.x","article-title":"Distribution of melatonin in mammalian tissues: the relative importance of nuclear versus cytosolic localization","volume":"15","author":"Menendez-Pelaez","year":"1993","journal-title":"J Pineal Res"},{"key":"10.1016\/j.nefro.2019.06.009_bib1040","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1600-079X.2011.00931.x","article-title":"Extrapineal melatonin: analysis of its subcellular distribution and daily fluctuations brain and liver extrapineal melatonin distribution","volume":"52","author":"Venegas","year":"2012","journal-title":"J Pineal Res"},{"key":"10.1016\/j.nefro.2019.06.009_bib1045","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/jpi.12360","article-title":"Melatonin as an antioxidant: under promises but over delivers","volume":"61","author":"Reiter","year":"2016","journal-title":"J Pineal Res"},{"key":"10.1016\/j.nefro.2019.06.009_bib1050","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1600-079X.2010.00815.x","article-title":"The role of mitochondrial complex III in melatonin-induced ROS production in cultured mesangial cells","volume":"50","author":"Zhang","year":"2011","journal-title":"J Pineal Res"},{"key":"10.1016\/j.nefro.2019.06.009_bib1055","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1600-079X.2011.00894.x","article-title":"Impaired mitochondrial complex III and melatonin responsive reactive oxygen species generation in kidney mitochondria of db\/db mice","volume":"51","author":"Zhang","year":"2011","journal-title":"J Pineal Res"},{"key":"10.1016\/j.nefro.2019.06.009_bib1060","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1385\/ENDO:27:2:119","article-title":"Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance","volume":"27","author":"Hardeland","year":"2005","journal-title":"Endocrine"},{"key":"10.1016\/j.nefro.2019.06.009_bib1065","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1034\/j.1600-079X.2001.300201.x","article-title":"Melatonin, mitochondria, and cellular bioenergetics","volume":"30","author":"Acu\u00f1a-Castroviejo","year":"2001","journal-title":"J Pineal Res"},{"key":"10.1016\/j.nefro.2019.06.009_bib1070","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/jpi.12128","article-title":"Protective effects of melatonin in reducing oxidative stress and in preserving the fluidity of biological membranes: a review","volume":"56","author":"Garc\u00eda","year":"2014","journal-title":"J Pineal Res"},{"key":"10.1016\/j.nefro.2019.06.009_bib1075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3835(00)00568-1","article-title":"Renal toxicity of the carcinogen delta-aminolevulinic acid: antioxidant effects of melatonin","volume":"161","author":"Karbownik","year":"2000","journal-title":"Cancer Lett"},{"key":"10.1016\/j.nefro.2019.06.009_bib1080","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0014-5793(97)00447-X","article-title":"Melatonin prevents changes in microsomal membrane fluidity during induced lipid peroxidation","volume":"408","author":"Garcia","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1016\/j.nefro.2019.06.009_bib1085","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1600-079X.2009.00721.x","article-title":"Visualization of melatonin's multiple mitochondrial levels of protection against mitochondrial Ca(2+)-mediated permeability transition and beyond in rat brain astrocytes","volume":"48","author":"Jou","year":"2010","journal-title":"J Pineal Res"},{"key":"10.1016\/j.nefro.2019.06.009_bib1090","doi-asserted-by":"crossref","first-page":"e111141","DOI":"10.1371\/journal.pone.0111141","article-title":"Mitochondrial and metabolic dysfunction in renal convoluted tubules of obese mice: protective role of melatonin","volume":"9","author":"Stacchiotti","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nefro.2019.06.009_bib1095","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1080\/08880010590964381","article-title":"Severe neurotoxicity, ototoxicity and nephrotoxicity following high-dose cisplatin and amifostine","volume":"22","author":"Sastry","year":"2005","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.nefro.2019.06.009_bib1100","first-page":"47","article-title":"Cisplatin nephrotoxicity: molecular mechanisms","volume":"1","author":"Hanigan","year":"2003","journal-title":"Cancer Ther"},{"key":"10.1016\/j.nefro.2019.06.009_bib1105","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/MAJ.0b013e31812dfe1e","article-title":"Cisplatin nephrotoxicity: a review","volume":"334","author":"Yao","year":"2007","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.nefro.2019.06.009_bib1110","doi-asserted-by":"crossref","first-page":"332","DOI":"10.5935\/0101-2800.20130052","article-title":"Acute nephrotoxicity of cisplatin: molecular mechanisms","volume":"35","author":"Peres","year":"2013","journal-title":"J Bras Nefrol"},{"key":"10.1016\/j.nefro.2019.06.009_bib1115","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1472-8206.2000.tb00440.x","article-title":"The protective effect of melatonin on cisplatin nephrotoxicity","volume":"14","author":"Sener","year":"2000","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.nefro.2019.06.009_bib1120","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1034\/j.1600-079X.2002.02910.x","article-title":"Physiological and pharmacological concentrations of melatonin protect against cisplatin-induced acute renal injury","volume":"33","author":"Parlakpinar","year":"2002","journal-title":"J Pineal Res"},{"key":"10.1016\/j.nefro.2019.06.009_bib1125","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1034\/j.1600-079X.2001.300301.x","article-title":"Melatonin, a pineal secretory product with antioxidant properties, protects against cisplatin-induced nephrotoxicity in rats","volume":"30","author":"Hara","year":"2001","journal-title":"J Pineal Res"},{"key":"10.1016\/j.nefro.2019.06.009_bib1130","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0024-3205(02)02480-3","article-title":"Melatonin prevents the increase in hydroxyl radical-spin trap adduct formation caused by the addition of cisplatin in vitro","volume":"72","author":"Yoshida","year":"2003","journal-title":"Life Sci"},{"key":"10.1016\/j.nefro.2019.06.009_bib1135","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1743-7075-10-7","article-title":"Melatonin suppresses cisplatin-induced nephrotoxicity via activation of Nrf-2\/HO-1 pathway","volume":"10","author":"Kilic","year":"2013","journal-title":"Nutr Metab"},{"key":"10.1016\/j.nefro.2019.06.009_bib1140","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1136\/adc.65.7.732","article-title":"Nephrotoxicity after ifosfamide","volume":"65","author":"Skinner","year":"1990","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.nefro.2019.06.009_bib1145","first-page":"38","article-title":"Ifosfamide in the treatment of breast cancer","volume":"23","author":"Overmoyer","year":"1996","journal-title":"Semin Oncol"},{"key":"10.1016\/j.nefro.2019.06.009_bib1150","first-page":"40","article-title":"Ifosfamide in non-small cell lung cancer: a review","volume":"19","author":"Eberhardt","year":"1992","journal-title":"Semin Oncol"},{"key":"10.1016\/j.nefro.2019.06.009_bib1155","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1634\/theoncologist.12-11-1351","article-title":"The pharmacologic basis of ifosfamide use in adult patients with advanced soft tissue sarcomas","volume":"12","author":"Tascilar","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.nefro.2019.06.009_bib1160","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0090-9556(24)15102-1","article-title":"Metabolism of ifosfamide to chloroacetaldehyde contributes to antitumor activity in vivo","volume":"28","author":"Borner","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.nefro.2019.06.009_bib1165","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/(SICI)1099-1263(199701)17:1<75::AID-JAT397>3.0.CO;2-C","article-title":"Ifosfamide metabolite chloroacetaldehyde causes renal dysfunction in vivo","volume":"17","author":"Springate","year":"1997","journal-title":"J Appl Toxicol"},{"key":"10.1016\/j.nefro.2019.06.009_bib1170","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1021\/mp100329u","article-title":"New clues for nephrotoxicity induced by ifosfamide: preferential renal uptake via the human organic cation transporter 2","volume":"8","author":"Ciarimboli","year":"2011","journal-title":"Mol Pharm"},{"key":"10.1016\/j.nefro.2019.06.009_bib1175","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1006\/taap.1994.1241","article-title":"Ifosfamide metabolite chloroacetaldehyde causes Fanconi syndrome in the perfused rat kidney","volume":"129","author":"Zamlauski-Tucker","year":"1994","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.nefro.2019.06.009_bib1180","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1600-079X.2004.00131.x","article-title":"Melatonin attenuates ifosfamide-induced Fanconi syndrome in rats","volume":"37","author":"Sener","year":"2004","journal-title":"J Pineal Res"},{"key":"10.1016\/j.nefro.2019.06.009_bib1185","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF02893506","article-title":"Anthracycline antibiotics induce acute renal tubular toxicity in children with cancer","volume":"13","author":"Bardi","year":"2007","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.nefro.2019.06.009_bib1190","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0169-409X(01)00128-4","article-title":"Mitochondria as subcellular targets for clinically useful anthracyclines","volume":"49","author":"Jung","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nefro.2019.06.009_bib1195","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0163-7258(90)90088-J","article-title":"Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity","volume":"47","author":"Keizer","year":"1990","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.nefro.2019.06.009_bib1200","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1016\/0006-2952(86)90713-6","article-title":"A possible role for membrane lipid peroxidation in anthracycline nephrotoxicity","volume":"35","author":"Mimnaugh","year":"1986","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.nefro.2019.06.009_bib1205","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1159\/000190202","article-title":"Hyperlipidemic nephropathy induced by adriamycin: effect of melatonin administration","volume":"76","author":"Montilla","year":"1997","journal-title":"Nephron"},{"key":"10.1016\/j.nefro.2019.06.009_bib1210","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1034\/j.1600-079X.2002.02902.x","article-title":"Role of exogenous melatonin in reducing the nephrotoxic effect of daunorubicin and doxorubicin in the rat","volume":"33","author":"Dziegiel","year":"2002","journal-title":"J Pineal Res"},{"issue":"Suppl. 1","key":"10.1016\/j.nefro.2019.06.009_bib1215","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.33549\/physiolres.932614","article-title":"Protective effect of captopril, olmesartan, melatonin and compound 21 on doxorubicin-induced nephrotoxicity in rats","volume":"62","author":"Hrenak","year":"2013","journal-title":"Physiol Res"},{"key":"10.1016\/j.nefro.2019.06.009_bib1220","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1634\/theoncologist.11-6-694","article-title":"Understanding and managing methotrexate nephrotoxicity","volume":"11","author":"Widemann","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.nefro.2019.06.009_bib1225","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1191\/0748233706th265oa","article-title":"Methotrexate-induced renal oxidative stress in rats: the role of a novel antioxidant caffeic acid phenethyl ester","volume":"22","author":"Oktem","year":"2006","journal-title":"Toxicol Ind Health"},{"key":"10.1016\/j.nefro.2019.06.009_bib1230","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1034\/j.1600-079X.2003.00043.x","article-title":"Melatonin prevents methotrexate-induced hepatorenal oxidative injury in rats","volume":"34","author":"Jahovic","year":"2003","journal-title":"J Pineal Res"},{"key":"10.1016\/j.nefro.2019.06.009_bib1235","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/cbf.1676","article-title":"Melatonin attenuates methotrexate-induced oxidative stress and renal damage in rats","volume":"28","author":"Abraham","year":"2010","journal-title":"Cell Biochem Funct"},{"key":"10.1016\/j.nefro.2019.06.009_bib1240","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF00756763","article-title":"Toxic effects of mechlorethamine on mammalian respiratory mucociliary epithelium in primary culture","volume":"10","author":"Giuliani","year":"1994","journal-title":"Cell Biol Toxicol"},{"key":"10.1016\/j.nefro.2019.06.009_bib1245","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1016\/0006-2952(92)90639-Z","article-title":"Hepatocyte toxicity of mechlorethamine and other alkylating anticancer drugs Role of lipid peroxidation","volume":"43","author":"Khan","year":"1992","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.nefro.2019.06.009_bib1250","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.jss.2011.11.002","article-title":"Protective effects of melatonin and S-methylisothiourea on mechlorethamine induced nephrotoxicity","volume":"175","author":"Kunak","year":"2012","journal-title":"J Surg Res"},{"key":"10.1016\/j.nefro.2019.06.009_bib1255","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1128\/AAC.00892-09","article-title":"Aminoglycoside use in intensive care units and aminoglycoside nephrotoxicity Comment letter 1","volume":"54","author":"Pogue","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.nefro.2019.06.009_bib1260","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/infdis\/138.4.541","article-title":"Comparative nephrotoxicity of aminoglycoside antibiotics in rats","volume":"138","author":"Luft","year":"1978","journal-title":"J Infect Dis"},{"key":"10.1016\/j.nefro.2019.06.009_bib1265","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/ki.2010.337","article-title":"New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view","volume":"79","author":"Lopez-Novoa","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefro.2019.06.009_bib1270","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000045650","article-title":"Melatonin, a pineal hormone with antioxidant property, protects against gentamicin-induced nephrotoxicity in rats","volume":"85","author":"Shifow","year":"2000","journal-title":"Nephron"},{"key":"10.1016\/j.nefro.2019.06.009_bib1275","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1046\/j.1464-410x.2000.00531.x","article-title":"Melatonin administration prevents the nephrotoxicity induced by gentamicin","volume":"85","author":"Ozbek","year":"2000","journal-title":"BJU Int"},{"key":"10.1016\/j.nefro.2019.06.009_bib1280","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1034\/j.1600-079X.2002.01858.x","article-title":"Melatonin protects against gentamicin-induced nephrotoxicity in rats","volume":"32","author":"Sener","year":"2002","journal-title":"J Pineal Res"},{"key":"10.1016\/j.nefro.2019.06.009_bib1285","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1472-8206.2009.00702.x","article-title":"A prospective comparative study of gentamicin- and amikacin-induced nephrotoxicity in patients with normal baseline renal function","volume":"23","author":"Sweileh","year":"2009","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.nefro.2019.06.009_bib1290","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1034\/j.1600-079X.2003.00059.x","article-title":"Amikacin-induced acute renal injury in rats: protective role of melatonin","volume":"35","author":"Parlakpinar","year":"2003","journal-title":"J Pineal Res"},{"key":"10.1016\/j.nefro.2019.06.009_bib1295","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/jac\/dkm511","article-title":"Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model","volume":"61","author":"Bergen","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.nefro.2019.06.009_bib1300","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1128\/AAC.01733-10","article-title":"Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients","volume":"55","author":"Garonzik","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.nefro.2019.06.009_bib1305","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00228-015-1865-4","article-title":"A review on colistin nephrotoxicity","volume":"71","author":"Ordooei Javan","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.nefro.2019.06.009_bib1310","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1128\/AAC.00328-11","article-title":"Melatonin attenuates colistin-induced nephrotoxicity in rats","volume":"55","author":"Yousef","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.nefro.2019.06.009_bib1315","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2146\/ajhp080434","article-title":"Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists","volume":"66","author":"Rybak","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.nefro.2019.06.009_bib1320","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s00228-012-1259-9","article-title":"Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review","volume":"68","author":"Elyasi","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.nefro.2019.06.009_bib1325","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1177\/2042018816638223","article-title":"Review of vancomycin-induced renal toxicity: an update","volume":"7","author":"Bamgbola","year":"2016","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.nefro.2019.06.009_bib1330","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1742-7843.2005.pto_153.x","article-title":"Protective effects of different antioxidants and amrinone on vancomycin-induced nephrotoxicity","volume":"97","author":"Celik","year":"2005","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.nefro.2019.06.009_bib1335","first-page":"240","article-title":"Ciprofloxacin-induced crystal nephropathy","volume":"8","author":"Kammoun","year":"2014","journal-title":"Iran J Kidney Dis"},{"key":"10.1016\/j.nefro.2019.06.009_bib1340","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000168458","article-title":"Ciprofloxacin-induced acute interstitial nephritis","volume":"12","author":"Bailey","year":"1992","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.nefro.2019.06.009_bib1345","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/sj.bmt.1701256","article-title":"Ciprofloxacin-associated acute renal failure in patients undergoing high-dose chemotherapy and autologous stem cell rescue","volume":"21","author":"Raja","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.nefro.2019.06.009_bib1350","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/j.1875-9114.1990.tb02592.x","article-title":"Renal dysfunction associated with ciprofloxacin","volume":"10","author":"Hatton","year":"1990","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.nefro.2019.06.009_bib1355","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.biopha.2016.10.053","article-title":"Melatonin can attenuate ciprofloxacin induced nephrotoxicity: Involvement of nitric oxide and TNF-alpha","volume":"84","author":"Shaki","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.nefro.2019.06.009_bib1360","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00228-014-1712-z","article-title":"Tenofovir-induced nephrotoxicity: incidence, mechanism, risk factors, prognosis and proposed agents for prevention","volume":"70","author":"Jafari","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.nefro.2019.06.009_bib1365","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/ki.2010.344","article-title":"Tenofovir-induced kidney disease: an acquired renal tubular mitochondriopathy","volume":"78","author":"Perazella","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefro.2019.06.009_bib1370","first-page":"1","article-title":"Preclinical efficacy of melatonin in the amelioration of tenofovir nephrotoxicity by the attenuation of oxidative stress, nitrosative stress, and inflammation in rats","author":"Ramamoorthy","year":"2014","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"10.1016\/j.nefro.2019.06.009_bib1375","first-page":"493","article-title":"Cyclosporine in transplantation \u2013 a history of converging timelines","volume":"25","author":"Colombo","year":"2011","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.1016\/j.nefro.2019.06.009_bib1380","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/ki.1996.415","article-title":"Chronic cyclosporine nephropathy: the Achilles\u2019 heel of immunosuppressive therapy","volume":"50","author":"Bennett","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefro.2019.06.009_bib1385","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1056\/NEJM199408113310604","article-title":"Long-term efficacy and safety of cyclosporine in renal-transplant recipients","volume":"331","author":"Burke","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefro.2019.06.009_bib1390","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0270-9295(03)00090-1","article-title":"Cyclosporine nephrotoxicity","volume":"23","author":"Burdmann","year":"2003","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.nefro.2019.06.009_bib1395","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/00007890-199904150-00022","article-title":"Melatonin: an antioxidant protects against cyclosporine-induced nephrotoxicity","volume":"67","author":"Kumar","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.nefro.2019.06.009_bib1400","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/S0041-1345(00)01492-5","article-title":"Effect of melatonin on renal function in cyclosporine nephrotoxicity","volume":"32","author":"Mun","year":"2000","journal-title":"Transplant Proc"},{"key":"10.1016\/j.nefro.2019.06.009_bib1405","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/01913120252959254","article-title":"Cyclosporine A-induced kidney alterations are limited by melatonin in rats: an electron microscope study","volume":"26","author":"Stacchiotti","year":"2002","journal-title":"Ultrastruct Pathol"},{"key":"10.1016\/j.nefro.2019.06.009_bib1410","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/10715760290019381","article-title":"Melatonin prevents cyclosporine-induced nephrotoxicity in isolated and perfused rat kidney","volume":"36","author":"Longoni","year":"2002","journal-title":"Free Radic Res"},{"key":"10.1016\/j.nefro.2019.06.009_bib1415","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2215\/CJN.04800908","article-title":"Calcineurin inhibitor nephrotoxicity","volume":"4","author":"Naesens","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2019.06.009_bib1420","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/1553350610381088","article-title":"The effect of melatonin against FK506-induced renal oxidative stress in rats","volume":"18","author":"Ara","year":"2011","journal-title":"Surg Innov"},{"key":"10.1016\/j.nefro.2019.06.009_bib1425","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/BF03160941","article-title":"Acetaminophen-induced nephrotoxicity: pathophysiology, clinical manifestations, and management","volume":"4","author":"Mazer","year":"2008","journal-title":"J Med Toxicol"},{"key":"10.1016\/j.nefro.2019.06.009_bib1430","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1034\/j.1600-079X.2003.00050.x","article-title":"Protective effects of melatonin, vitamin E and N-acetylcysteine against acetaminophen toxicity in mice: a comparative study","volume":"35","author":"Sener","year":"2003","journal-title":"J Pineal Res"},{"key":"10.1016\/j.nefro.2019.06.009_bib1435","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.2174\/092986710791233689","article-title":"Clinical uses of melatonin: evaluation of human trials","volume":"17","author":"Sanchez-Barcelo","year":"2010","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.nefro.2019.06.009_bib1440","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1517\/13543776.2014.1001739","article-title":"Therapeutic uses of melatonin and melatonin derivatives: a patent review (2012\u20132014)","volume":"25","author":"Rivara","year":"2015","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.nefro.2019.06.009_bib1445","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1021\/jm050746d","article-title":"Novel tacrine-melatonin hybrids as dual-acting drugs for Alzheimer disease, with improved acetylcholinesterase inhibitory and antioxidant properties","volume":"49","author":"Rodriguez-Franco","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.nefro.2019.06.009_bib1450","first-page":"109","article-title":"Urinary sodium excretion in patients with nephrotic syndrome, and its circadian variation","volume":"87","author":"Koopman","year":"1994","journal-title":"Q J Med"},{"key":"10.1016\/j.nefro.2019.06.009_bib1455","doi-asserted-by":"crossref","first-page":"H670","DOI":"10.1152\/ajpheart.00710.2010","article-title":"Melatonin differentially affects vascular blood flow in humans","volume":"300","author":"Cook","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.nefro.2019.06.009_bib1460","first-page":"191","article-title":"[Circadian rhythm and renal colic]","volume":"94","author":"Boari","year":"2003","journal-title":"Recenti Prog Med"},{"key":"10.1016\/j.nefro.2019.06.009_bib1465","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/ndt\/gfr216","article-title":"The melatonin receptor 1A (MTNR1A) gene is associated with recurrent and idiopathic calcium nephrolithiasis","volume":"27","author":"Esposito","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefro.2019.06.009_bib1470","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/ndt\/gfp493","article-title":"Impairment of endogenous melatonin rhythm is related to the degree of chronic kidney disease (CREAM study)","volume":"25","author":"Koch","year":"2010","journal-title":"Nephrol Dial Transplant Nephrol Dial Transplant"},{"key":"10.1016\/j.nefro.2019.06.009_bib1475","unstructured":"Hospital BaWs. Effects of melatonin supplementation on renal physiology in a habitual sleep restricted population. ClinicalTrials.gov Identifier: NCT02631148, 2018."},{"key":"10.1016\/j.nefro.2019.06.009_bib1480","unstructured":"Southeast Renal Research I. Different doses of oral melatonin supplements in chronic kidney disease (CKD)-associated sleep disorders. ClinicalTrials.gov Identifier: NCT01922999, 2017."},{"key":"10.1016\/j.nefro.2019.06.009_bib1485","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000020263","article-title":"Abrogation of the negative influence of opioids on IL-2 immunotherapy of renal cell cancer by melatonin","volume":"38","author":"Lissoni","year":"2000","journal-title":"Eur Urol"},{"key":"10.1016\/j.nefro.2019.06.009_bib1490","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0272-6386(01)80124-4","article-title":"Melatonin prevents oxidative stress resulting from iron and erythropoietin administration","volume":"37","author":"Herrera","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nefro.2019.06.009_bib1495","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1600-079X.2006.00353.x","article-title":"Effects of melatonin and zinc on lipid profile and renal function in type 2 diabetic patients poorly controlled with metformin","volume":"41","author":"Kadhim","year":"2006","journal-title":"J Pineal Res"},{"key":"10.1016\/j.nefro.2019.06.009_bib1500","unstructured":"Rigatto MHP. Melatonin for renal protection in patients receiving polymyxin B. ClinicalTrials.gov Identifier: NCT03725267, 2020."}],"container-title":["Nefrolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699519301584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699519301584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T12:53:44Z","timestamp":1759323224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0211699519301584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":150,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0211699519301584"],"URL":"https:\/\/doi.org\/10.1016\/j.nefro.2019.06.009","relation":{},"ISSN":["0211-6995"],"issn-type":[{"value":"0211-6995","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Melatonin ameliorates the drug induced nephrotoxicity: Molecular insights","name":"articletitle","label":"Article Title"},{"value":"Nefrolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nefro.2019.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedad Espa\u00f1ola de Nefrolog\u00eda.","name":"copyright","label":"Copyright"}]}}